Taryn Elise Travis

Dr. Taryn Elise Travis

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 March 2023 in Surgical Clinics of North America
Verified
Journal Article
Closed access
STShawn Tejiram
Shawn Tejiram
STStephen P. Tranchina
Stephen P. Tranchina
TTTaryn Elise Travis
Taryn Elise Travis
JSJeffrey W. Shupp
Jeffrey W. Shupp

1 January 2022 in The American Journal of Surgery
Verified
Journal Article
Closed access
LNLauren B. Nosanov
Lauren B. Nosanov
NPNicholas J. Prindeze
Nicholas J. Prindeze
DSDaniel M. Schneider
Daniel M. Schneider
LCLisa E. Clemente
Lisa E. Clemente
KPKatherine R. Parrish
Katherine R. Parrish
LJLaura S. Johnson
Laura S. Johnson

11 September 2024 in Journal of Burn Care & Research
Verified
Journal Article
Closed access
PDF file
ESEloise W Stanton
Eloise W Stanton
AMArtur Manasyan
Artur Manasyan
CTCallie M Thompson
Callie M Thompson
GPGourang P Patel
Gourang P Patel
ALAlexandra M Lacey
Alexandra M Lacey
JGJustin Gillenwater
Justin Gillenwater
Comprehensive studies on the incidence, risk factors, and prophylactic measures related to venous thromboembolism (VTE) are lacking in burn care. This study characterizes VTE risk and existing prevention measures to improve and inform overall patient care in the field of burn care on a national scale. The US National Trauma Data Bank was queried from 2007 to 2021 to identify burn-injured patients. Descriptive statistics and multivariate regression analyses were used to explore the association between demographic/clinical characteristics and VTE risk as well as compare various VTE chemoprophylaxis types. There were 326 614 burn-injured patients included for analysis; 5642 (1.7%) experienced a VTE event during their hospitalization. Patients with VTE were significantly older, had greater body mass indexes and % total body surface area, and were more likely to be male (P < .001). History of smoking, hypertension or myocardial infarction, and/or substance use disorder were significant predictors of VTE (P < .001). Patients who received low molecular weight heparin were less likely to have VTE compared to patients treated with heparin when controlling for other VTE risk factors (odds ratio [OR]: 0.564, 95% confidence interval [95% CI]: 0.523-0.607, P < .001). Longer time to VTE chemoprophylaxis (>6 h) initiation was significantly associated with VTE (OR = 1.04, 95% CI: 1.03-1.07, P < .001). This study sheds light on risk factors and chemoprophylaxis in VTE to help guide clinical practice when implementing prevention strategies in patients with burns. This knowledge can be leveraged to refine risk stratification models, inform evidence-based prevention strategies, and ultimately enhance the quality of care for patients with burns at risk of VTE.

1 August 2017 in Journal of Surgical Research
Verified
Journal Article
Closed access
LNLauren B. Nosanov
Lauren B. Nosanov
MMMelissa M. McLawhorn
Melissa M. McLawhorn
LHLamisa Hassan
Lamisa Hassan
TTTaryn Elise Travis
Taryn Elise Travis
STShawn Tejiram
Shawn Tejiram
JSJeffrey W. Shupp
Jeffrey W. Shupp

7 July 2024 in Lasers in Surgery and Medicine
Verified
Journal Article
Open access
VSVictoria Slavinsky
Victoria Slavinsky
JWJasmine H. Wong
Jasmine H. Wong
BCBonnie C. Carney
Bonnie C. Carney
DLDavon T. Lee
Davon T. Lee
RARebekah Allely
Rebekah Allely
TTTaryn Elise Travis
Taryn Elise Travis
Objectives: Fractional ablative CO2 laser (FLSR) is used to treat hypertrophic scars (HTSs) resulting from burn injuries, which are characterized by factors, such as erythema, contracture, thickness, and symptoms of pain and itch. Traditionally, waiting a year after injury for scar maturation before starting laser treatment has been recommended; however, the potential benefits of earlier intervention have gained popularity. Still, the optimal timing for beginning laser intervention in patients with HTSs remains uncertain. This study aims to evaluate the ideal timing for the initiation of FLSR for HTSs using several qualitative and quantitative assessment measures. It was hypothesized that early intervention would lead to similar improvement trends as later intervention, however, would be more ideal due to the shortened time without symptom relief for patients.Methods: Patients who received three or more laser treatment sessions and completed both pre‐ and posttreatment evaluations were included in this analysis (n = 69). FLSR treatment was administered at 4–8‐week intervals. Patients starting treatment before 6 months after injury were classified as the early‐stage intervention group and those beginning treatment at 6–12 months after injury were classified as the late‐stage intervention group. Demographic data, including the age of patients at the time of first treatment, age of scars at the time of first treatment, biological sex, ethnicity, Fitzpatrick skin type, and use of laser‐assisted drug delivery, were collected by retrospective chart review. Patients were evaluated on six subjective scales and objectively for scar stiffness with durometry. For all scales, higher scores indicate worse scars. A two‐way ANOVA, Student's t‐test, and Mann–Whitney U‐test were used to compare scores from the pre‐ to posttreatment evaluations.Results: There were no significant differences between the groups for any of the demographic or scar‐specific variables; thus, differences in outcome can be attributed to the timing of intervention. Both groups demonstrated an improvement in scars with treatment over time (p < 0.05). Both early‐ and middle‐stage initiation showed scar symptom improvement in five out of six scales. In the late‐stage intervention, the Patient and Observer Scar Assessment Scale‐Patient average score did not show improvement. In the early‐stage intervention, the Vancouver Scar Scale total did not show improvement. Quantitative evaluation of scar stiffness by durometry did not show symptom improvement in either group. The Scar Comparison Scale demonstrated the greatest improvement across groups.Conclusion: Laser treatment led to scar improvement in at least one scale at each stage of initiation. Both intervention timelines resulted in equivalent outcomes, and early intervention should be considered when initiating FLSR treatment in burn scars to alleviate symptoms earlier.

8 February 2023 in Journal of Burn Care & Research
Verified
Journal Article
Closed access
PDF file
BCBonnie C Carney
Bonnie C Carney
JBJohn K Bailey
John K Bailey
HPHeather M Powell
Heather M Powell
DSDorothy M Supp
Dorothy M Supp
TTTaryn Elise Travis
Taryn Elise Travis
Burn scars, and in particular, hypertrophic scars, are a challenging yet common outcome for survivors of burn injuries. In 2021, the American Burn Association brought together experts in burn care and research to discuss critical topics related to burns, including burn scars, at its State of the Science conference. Clinicians and researchers with burn scar expertise, as well as burn patients, industry representatives, and other interested stakeholders met to discuss issues related to burn scars and discuss priorities for future burn scar research. The various preventative strategies and treatment modalities currently utilized for burn scars were discussed, including relatively noninvasive therapies such as massage, compression, and silicone sheeting, as well as medical interventions such as corticosteroid injection and laser therapies. A common theme that emerged is that the efficacy of current therapies for specific patient populations is not clear, and further research is needed to improve upon these treatments and develop more effective strategies to suppress scar formation. This will necessitate quantitative analyses of outcomes and would benefit from creation of scar biobanks and shared data resources. In addition, outcomes of importance to patients, such as scar dyschromia, must be given greater attention by clinicians and researchers to improve overall quality of life in burn survivors. Herein we summarize the main topics of discussion from this meeting and offer recommendations for areas where further research and development are needed.